Bedrosian Camille L
SEC CIK 1326969 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | Chief Medical Off | 278.1K | — | $798.8K | 12 | 2023-11-27 | 2026-09-10 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Dir | 7,000 | — | — | 2 | 2024-06-21 | 2025-06-18 |
| RARE | Ultragenyx Pharmaceutical Inc. | EVP, Chief Medical Off | 50.6K | — | $1.00M | 8 | 2021-09-01 | 2023-03-01 |
Most active insiders at AMLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| 2 | Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| 3 | Mazzariello Gina | CLO | — | $1.18M |
| 4 | FRATES JAMES M | CFO | — | $708.4K |
| 5 | Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| 6 | Firestone Karen | Dir | $152.2K | — |
| 7 | MILNE GEORGE M JR | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-14 16:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $32.40 | -10.0K | 278.1K | -3% | -$324.9K |
| 2026-08-20 21:00 | 2026-08-18 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +22.8K | 288.1K | +9% | $0 | |
| D | 2026-03-09 | 2026-03-05 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +96.0K | 265.3K | +57% | $0 |
| 2026-03-04 | 2026-03-02 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $14.58 | -6,461 | 169.3K | -4% | -$94.2K | |
| 2025-12-03 | 2025-12-01 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $14.35 | -6,580 | 175.8K | -4% | -$94.4K | |
| 2025-10-02 | 2025-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $14.58 | -12.0K | 182.3K | -6% | -$175.5K | |
| D | 2025-06-23 | 2025-06-18 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Bedrosian Camille L | Dir | M - OptEx | — | +4,000 | 7,000 | +133% | — |
| 2025-04-02 | 2025-03-31 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $3.47 | -12.4K | 194.4K | -6% | -$43.1K | |
| D | 2025-03-10 | 2025-03-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +68.4K | 206.8K | +49% | $0 |
| 2024-12-03 | 2024-12-02 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $5.54 | -5,421 | 138.4K | -4% | -$30.0K | |
| 2024-10-02 | 2024-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | S - Sale | $3.20 | -11.4K | 143.8K | -7% | -$36.6K | |
| D | 2024-06-25 | 2024-06-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Bedrosian Camille L | Dir | M - OptEx | — | +3,000 | 3,000 | New | — |
| D | 2024-04-18 | 2024-04-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +96.9K | 155.2K | +166% | $0 |
| D | 2023-11-29 | 2023-11-27 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +58.3K | 58.3K | New | $0 |
| 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | A - Grant | $0.00 | +2,663 | 50.6K | +6% | $0 | |
| 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $45.25 | -3,881 | 46.7K | -8% | -$175.6K | |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $66.62 | -2,821 | 33.9K | -8% | -$187.9K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | A - Grant | $0.00 | +14.0K | 47.9K | +41% | $0 |
| 2022-02-01 | 2022-01-30 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $66.30 | -1,657 | 36.8K | -4% | -$109.9K | |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $81.14 | -359 | 38.4K | -0.9% | -$29.1K | |
| DM | 2021-09-02 | 2021-09-01+ | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | M - OptEx | $55.00 | +5,000 | 41.3K | +14% | +$275.0K |
| DM | 2021-09-02 | 2021-09-01+ | RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale+OE | $100.11 | -5,000 | 38.8K | -11% | -$500.5K |
Purchase Sale Sale after option exercise All abbreviations